A good-faith exam (GFE) is the clinical foundation of prescribing authority for aesthetic injectables and devices. Unlike pharmaceutical prescriptions, which rely on established diagnoses, aesthetic GFEs must establish that the patient is appropriate for treatment, free of contraindications, and has realistic expectations. The rules vary significantly by state—some allow nurse practitioners and physician assistants to conduct exams independently; others require physician oversight. Telehealth has further fractured the landscape: a handful of states permit remote GFEs for injectables, while most require in-person evaluation. For practice owners, understanding your state's specific standard is non-negotiable; misalignment between exam scope and prescriber credentials is a common audit finding and can trigger scope-of-practice violations, insurance denials, and board complaints. This page maps the structural requirements and flags where you need to verify current state rules.

What a Good-Faith Exam Actually Requires

A good-faith exam establishes a provider-patient relationship and documents clinical judgment that the patient is a suitable candidate for treatment. At minimum, the exam should include:

  • Patient history: medical and surgical history, current medications (especially anticoagulants, NSAIDs, immunosuppressants), allergies, and prior adverse reactions to injectables or topicals
  • Physical assessment: visual inspection of the treatment area, skin type/condition, facial anatomy, and any contraindications (active infection, severe skin disease, pregnancy/nursing status for certain agents)
  • Informed consent: discussion of risks, benefits, alternatives, realistic outcomes, and downtime
  • Documentation: contemporaneous notes linking clinical findings to the treatment plan

The exam does not require a full physical or laboratory work-up in most states, but it must be specific to the proposed treatment. A cursory "looks good" does not meet the standard. State boards and payers increasingly scrutinize whether the documented exam supports the treatment decision. If a patient presents with active herpes simplex and receives Botox anyway, the exam record must explain why (e.g., prophylactic antivirals prescribed). Absence of that reasoning is a red flag.

Who Can Perform the Exam: Scope-of-Practice Variation

Physicians (MDs, DOs) can always perform a GFE and delegate treatment to licensed nurses or PAs under supervision.

Nurse Practitioners (NPs) and Physician Assistants (PAs) have state-dependent autonomy:

  • Independent practice states (CA, TX, NY, FL, and others): NPs and PAs can conduct exams and prescribe/administer injectables without physician co-signature, provided they meet state licensing and continuing-education requirements
  • Collaborative/supervised states: NPs and PAs must work under a physician's protocol or standing order; the physician may not need to be present but must review and approve the exam and treatment plan
  • Restrictive states: Some states require physician presence or direct supervision for any injectable administration

Registered Nurses (RNs) and Licensed Estheticians cannot independently perform a GFE or prescribe; they administer under a provider's order. However, some states allow RNs to conduct a preliminary assessment (vital signs, history) that feeds into a physician's exam.

The Corporate Practice of Medicine doctrine (enforced in CA, TX, and others) further restricts who can own and operate an aesthetic practice. In these states, a non-physician cannot own a medical spa; a physician must be the owner or supervising partner. This affects your hiring and delegation structure.

In-Person vs. Telehealth: State-by-State Divergence

Telehealth GFEs for injectables remain highly restricted. Most state medical boards require in-person exams for aesthetic injectables because visual assessment of facial anatomy, skin texture, and asymmetry is considered essential.

States permitting remote GFEs (limited list):

  • California: NPs and PAs can conduct telehealth exams for Botox/fillers under specific protocols; physician oversight required
  • Texas: Telehealth exams allowed under established provider-patient relationship; some restrictions on first-time patients
  • Florida: Permits telehealth for established patients; new patients typically require in-person visit

Most states: Require in-person exam. Even during COVID, state boards clarified that aesthetic injectables do not qualify for remote-only prescribing.

Practical implication: If you operate in multiple states, you cannot assume a telehealth consultation in one state satisfies another's requirement. A patient who had a video consult in CA may still need an in-person exam before treatment in FL. Document the exam location and modality in your records. Some practices use hybrid models: telehealth for history/consent, in-person for physical exam and injection.

Documentation Standards and Audit Exposure

State boards and payers (especially Medicare/Medicaid) audit GFE documentation closely. Weak records are the leading cause of compliance findings.

Minimum documentation:

  • Date, time, and location of exam (in-person vs. telehealth)
  • Examiner credentials (name, license number, title)
  • Patient history: relevant medical/surgical history, medications, allergies
  • Physical findings: specific observations (e.g., "moderate glabellar lines, no active skin infection, symmetric facial structure")
  • Contraindications assessment: documented review and clearance
  • Informed consent: signed or electronically acknowledged
  • Treatment plan: specific product, dose, injection sites, rationale

Red flags that trigger audits:

  • Templated notes with no patient-specific detail
  • Exam performed by non-credentialed staff with no physician review
  • Telehealth exam in a state requiring in-person evaluation
  • Exam date after treatment date (retroactive documentation)
  • No documentation of informed consent

Insurance and board enforcement: Medicare Administrative Contractors (MACs) deny claims lacking adequate GFE documentation. State boards issue citations for scope-of-practice violations (e.g., RN conducting exam without provider order). Maintain exams in a separate, easily retrievable section of the patient record.

How to Verify Your State's Current Rules

GFE and telehealth rules evolve. Verify your state's current standard through:

  • State Medical Board: Most post scope-of-practice guidelines and telehealth policies online. Search "[State] medical board aesthetic injectables" or "telehealth policy"
  • State Nursing Board: For NP/RN scope clarification
  • State PA Board: For PA autonomy and supervision requirements
  • Professional societies: The American Society of Plastic Surgeons (ASPS), American Academy of Dermatology (AAD), and American Society of Aesthetic Plastic Surgeons (ASAPS) publish state-specific practice advisories
  • Your malpractice carrier: Often provides state-specific compliance summaries
  • Legal counsel: For practices operating in multiple states or with complex staffing models, a healthcare attorney familiar with your state's Corporate Practice of Medicine doctrine is essential

Do not rely on manufacturer guidance (e.g., Allergan's training materials) as a substitute for state law; manufacturers provide general best practices, not state-specific legal requirements. Update your protocols annually or whenever your state board issues new guidance.

Common Compliance Pitfalls and How to Avoid Them

Pitfall 1: Delegating exams to non-credentialed staff. RNs and estheticians cannot independently conduct GFEs. Solution: Establish a clear protocol where a licensed provider (MD, DO, NP, or PA per your state) reviews and documents the exam.

Pitfall 2: Telehealth in restrictive states. Offering remote consultations in states that require in-person exams exposes you to board complaints and insurance denials. Solution: Clarify your state's telehealth policy and enforce in-person exams where required. If you operate a multi-state practice, use geographic IP blocking or explicit disclaimers.

Pitfall 3: Inadequate informed consent. Verbal consent is not enough; document it. Solution: Use written or electronic consent forms specific to each treatment (Botox, filler, RF microneedling, etc.) and retain signed copies.

Pitfall 4: Exam-treatment timing gaps. Exams valid for 6–12 months vary by state and payer. Performing treatment 18 months after an exam may violate your state's standard. Solution: Establish a policy (e.g., "exams valid for 12 months") and flag charts for re-exam when approaching the limit.

Pitfall 5: Misaligned credentials and scope. Hiring an NP from an independent-practice state and deploying them in a supervised state without adjusting protocols causes violations. Solution: Map each staff member's credentials to your state's scope and document the supervision structure.

Bottom line

Good-faith exams are the legal and clinical bedrock of aesthetic practice; state rules on who performs them and whether telehealth qualifies vary sharply—verify your state's current standard and document exams rigorously.